Behavior of Regular Insulin in a Parenteral Nutrition Admixture: Validation of an LC/MS-MS Assay and the In Vitro Evaluation of Insulin Glycation.

LC-MS/MS drug stability study glycation parenteral nutrition admixture regular insulin

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
18 May 2022
Historique:
received: 18 03 2022
revised: 14 05 2022
accepted: 17 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 29 5 2022
Statut: epublish

Résumé

Parenteral-nutrition (PN)-induced hyperglycemia increases morbidity and mortality and must be treated with insulin. Unfortunately, the addition of insulin to a ternary PN admixture leads to a rapid decrease in insulin content. Our study's objective was to determine the mechanistic basis of insulin's disappearance. The literature data suggested the presence of a glycation reaction; we therefore validated an LC-MS/MS assay for insulin and glycated insulin. In a 24-h stability study, 20 IU/L of insulin was added to a binary PN admixture at pH 3.6 or 6.3. When the samples were diluted before analysis with a near-neutral diluent, insulin was fully stable at pH 3.6, while a loss of around 50% was observed at pH 6.3. Its disappearance was shown to be inversely correlated with the appearance of monoglycated insulin (probably a Schiff base adduct). Monoglycated insulin might also undergo a back-reaction to form insulin after acidic dilution. Furthermore, a second monoglycated insulin species appeared in the PN admixture after more than 24 h at high temperature (40 °C) and a high insulin concentration (1000 IU/L). It was stable at acidic pH and might be an Amadori product. The impact of insulin glycation under non-forced conditions on insulin's bioactivity requires further investigation.

Identifiants

pubmed: 35631667
pii: pharmaceutics14051081
doi: 10.3390/pharmaceutics14051081
pmc: PMC9148014
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Chromatogr A. 2009 Apr 3;1216(14):2953-7
pubmed: 19027906
J Acad Nutr Diet. 2013 Feb;113(2):263-8
pubmed: 23351630
Diabetes Care. 2013 May;36(5):1061-6
pubmed: 23223407
J Pharm Biomed Anal. 2007 Sep 21;45(1):82-96
pubmed: 17716847
Pharmaceutics. 2021 Mar 27;13(4):
pubmed: 33801784
Clin Ter. 2014;165(1):e17-23
pubmed: 24589955
Nutr Clin Pract. 2004 Apr;19(2):120-8
pubmed: 16215099
Regul Pept. 2003 May 15;113(1-3):1-8
pubmed: 12686455
Analyst. 2019 Jul 21;144(14):4139-4148
pubmed: 31143899
Methods. 2012 Feb;56(2):230-5
pubmed: 21871962
J Pharm Biomed Anal. 2010 Jun 5;52(2):195-202
pubmed: 20129751
Curr Diab Rep. 2013 Feb;13(1):155-62
pubmed: 23065369
Diabetes. 2003 Feb;52(2):492-8
pubmed: 12540626
J Biol Chem. 1981 May 25;256(10):5204-8
pubmed: 7228877
Dan Med J. 2018 Apr;65(4):
pubmed: 29619926
Mass Spectrom Rev. 2008 Jan-Feb;27(1):35-50
pubmed: 18000882
Ir Med J. 2014 May;107(5):141-3
pubmed: 24908857
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Sep 15;967:50-6
pubmed: 25073106
Pathol Biol (Paris). 2010 Jun;58(3):214-9
pubmed: 19896783
Antioxidants (Basel). 2021 Jul 15;10(7):
pubmed: 34356360
FEBS Lett. 1979 Apr 1;100(1):133-6
pubmed: 437095
Diabetes. 1996 Nov;45(11):1489-96
pubmed: 8866551
Diabetes Care. 2010 Apr;33(4):739-41
pubmed: 20040658
Clin Nutr. 2020 Feb;39(2):388-394
pubmed: 30930133
Pharmacotherapy. 2015 Feb;35(2):148-57
pubmed: 25689245
JPEN J Parenter Enteral Nutr. 2017 Sep;41(7):1110-1118
pubmed: 27091835
Clin Nutr ESPEN. 2021 Feb;41:275-280
pubmed: 33487276
Clin Chem Lab Med. 2006;44(11):1379-82
pubmed: 17087654
JPEN J Parenter Enteral Nutr. 2004 Nov-Dec;28(6):S39-70
pubmed: 15568296
Int J Mol Sci. 2017 Nov 28;18(12):
pubmed: 29182540
Peptides. 2000 Oct;21(10):1519-26
pubmed: 11068099
Pharm Res. 2015 Jun;32(6):2072-85
pubmed: 25583030
Biochim Biophys Acta. 2000 Sep 1;1523(1):128-34
pubmed: 11099867
Can J Gastroenterol. 2010 Jul;24(7):453-7
pubmed: 20652162
Int J Mol Sci. 2021 Jun 21;22(12):
pubmed: 34205510
Biochim Biophys Acta. 2005 Oct 10;1725(3):269-82
pubmed: 16165279
J Pharm Biomed Anal. 2015;111:344-50
pubmed: 25599910
JPEN J Parenter Enteral Nutr. 2018 Jul;42(5):846-854
pubmed: 28792863
Diabetes Metab. 2002 Dec;28(6 Pt 2):3S61-9; discussion 3S108-12
pubmed: 12688635
Appl Biochem Biotechnol. 2013 Jun;170(3):623-38
pubmed: 23584594
Diabetes. 1988 Jun;37(6):787-91
pubmed: 3289999
Anal Bioanal Chem. 2010 Jul;397(5):1985-95
pubmed: 20496032
J Nutr. 1982 Aug;112(8):1631-7
pubmed: 6808096
Clin Chem. 2004 Jan;50(1):257-9
pubmed: 14709671
Int J Legal Med. 2021 Sep;135(5):1813-1822
pubmed: 33932171
Diabetes Ther. 2018 Jun;9(3):1359-1367
pubmed: 29725969
J Pharm Biomed Anal. 2004 Nov 15;36(3):579-86
pubmed: 15522533
Endocr Pract. 2018 Oct 2;24(10):900-906
pubmed: 30035626
JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):755-62
pubmed: 23770842
Nahrung. 2001 Jun;45(3):150-9
pubmed: 11455780
J Pept Sci. 2004 Mar;10(3):119-37
pubmed: 15113085
Peptides. 1996;17(8):1323-30
pubmed: 8971927
J Pharm Sci. 2015 Apr;104(4):1555-60
pubmed: 25581527
JPEN J Parenter Enteral Nutr. 2014 Mar-Apr;38(3):334-77
pubmed: 24531708
J Agric Food Chem. 1976 May-Jun;24(3):465-7
pubmed: 5473
Acta Diabetol. 1997 Dec;34(4):265-70
pubmed: 9451470
J Chromatogr Sci. 2012 Aug;50(7):586-90
pubmed: 22525877
J Pharm Biomed Anal. 2007 Sep 21;45(1):70-81
pubmed: 17646076
Nutrition. 2015 Jan;31(1):58-63
pubmed: 25441588
Anal Bioanal Chem. 2017 May;409(14):3677-3684
pubmed: 28357482
Nutr Clin Pract. 2019 Oct;34(5):775-782
pubmed: 30693980
J Chromatogr B Biomed Sci Appl. 2000 Nov 10;749(1):25-34
pubmed: 11129075
Diabetes Care. 2020 Jul;43(7):e77-e78
pubmed: 32381586
J Am Soc Mass Spectrom. 2009 Jul;20(7):1319-26
pubmed: 19369093

Auteurs

Heloise Henry (H)

Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

Jean-François Goossens (JF)

Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

Mostafa Kouach (M)

Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

Damien Lannoy (D)

Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

David Seguy (D)

Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, F-59000 Lille, France.

Thierry Dine (T)

Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

Pascal Odou (P)

Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

Catherine Foulon (C)

Univ. Lille, CHU Lille, ULR 7365-GRITA-Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.

Classifications MeSH